Pemphigus Vulgaris Successfully Treated With Bromocriptine.
J Drugs Dermatol
; 23(3): e83-e85, 2024 Mar 01.
Article
em En
| MEDLINE
| ID: mdl-38443120
ABSTRACT
Pemphigus vulgaris (PV) is an autoimmune blistering skin condition primarily treated with immunosuppressive agents. We describe a case of PV successfully treated with nonconventional treatment, bromocriptine mesylate. Bromocriptine has been used in human trials showing beneficial therapeutic effects in managing autoimmune conditions. The results from experimental trials and the low toxicity of bromocriptine in comparison with immunosuppressive agents form a solid rationale for investigating its role in controlling PV. J Drugs Dermatol. 2024;23(3) doi10.36849/JDD.7720e.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doenças Autoimunes
/
Pênfigo
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article